| abstract |
The invention relates to the use of the trisubstituted benzopyranones of general formula (I), wherein R6, R7 and R8 independently represent H or SO3H, and to the physiologically acceptable salts thereof for use in the treatment or prophylaxis of pathological conditions that are related to oxidative stress and/or inflammatory reactions. The invention also relates to novel trisubstituted benzopyranones and to the physiologically acceptable salts thereof, and to plant extracts, drugs, dietetic food and pharmaceutical preparations containing said compounds. |